These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


508 related items for PubMed ID: 18562955

  • 1. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
    Wu MH, Chou YC, Yu CP, Yang T, You SL, Chen CJ, Sun CA.
    Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
    [Abstract] [Full Text] [Related]

  • 2. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
    Haiman CA, Brown M, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Kantoff PW, Hunter DJ.
    Cancer Res; 2002 Feb 15; 62(4):1045-9. PubMed ID: 11861380
    [Abstract] [Full Text] [Related]

  • 3. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
    Suter NM, Malone KE, Daling JR, Doody DR, Ostrander EA.
    Cancer Epidemiol Biomarkers Prev; 2003 Feb 15; 12(2):127-35. PubMed ID: 12582022
    [Abstract] [Full Text] [Related]

  • 4. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population.
    Giguère Y, Dewailly E, Brisson J, Ayotte P, Laflamme N, Demers A, Forest VI, Dodin S, Robert J, Rousseau F.
    Cancer Res; 2001 Aug 01; 61(15):5869-74. PubMed ID: 11479228
    [Abstract] [Full Text] [Related]

  • 5. Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.
    Wedrén S, Magnusson C, Humphreys K, Melhus H, Kindmark A, Stiger F, Branting M, Persson I, Baron J, Weiderpass E.
    Cancer Epidemiol Biomarkers Prev; 2007 Sep 01; 16(9):1775-83. PubMed ID: 17855696
    [Abstract] [Full Text] [Related]

  • 6. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW, Chokkalingam AP, Gao YT, Wu G, Wang X, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Chiang T, Chen YL, Stanczyk FZ, Chang C.
    Cancer Epidemiol Biomarkers Prev; 2002 Apr 01; 11(4):337-41. PubMed ID: 11927493
    [Abstract] [Full Text] [Related]

  • 7. Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women.
    Yu MW, Yang YC, Yang SY, Chang HC, Liaw YF, Lin SM, Liu CJ, Lee SD, Lin CL, Chen PJ, Lin SC, Chen CJ.
    Hepatology; 2002 Jul 01; 36(1):156-63. PubMed ID: 12085360
    [Abstract] [Full Text] [Related]

  • 8. Microsatellite profile in hormonal receptor genes associated with breast cancer.
    Iobagiu C, Lambert C, Normand M, Genin C.
    Breast Cancer Res Treat; 2006 Jan 01; 95(2):153-9. PubMed ID: 16317584
    [Abstract] [Full Text] [Related]

  • 9. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
    Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang C.
    Cancer Res; 2000 Sep 15; 60(18):5111-6. PubMed ID: 11016637
    [Abstract] [Full Text] [Related]

  • 10. Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene.
    González A, Javier Dorta F, Rodriguez G, Brito B, Rodríguez MA, Cabrera A, Díaz-Chico JC, Reyes R, Aguirre-Jaime A, Nicolás Díaz-Chico B.
    Eur J Cancer; 2007 Nov 15; 43(16):2373-80. PubMed ID: 17728127
    [Abstract] [Full Text] [Related]

  • 11. Androgen receptor gene polymorphism and breast cancer susceptibility in The Philippines.
    Liede A, Zhang W, De Leon Matsuda ML, Tan A, Narod SA.
    Cancer Epidemiol Biomarkers Prev; 2003 Sep 15; 12(9):848-52. PubMed ID: 14504193
    [Abstract] [Full Text] [Related]

  • 12. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.
    Kadouri L, Easton DF, Edwards S, Hubert A, Kote-Jarai Z, Glaser B, Durocher F, Abeliovich D, Peretz T, Eeles RA.
    Br J Cancer; 2001 Jul 06; 85(1):36-40. PubMed ID: 11437399
    [Abstract] [Full Text] [Related]

  • 13. Polymorphic CAG repeat length within the androgen receptor gene: identification of a subgroup of patients with increased risk of ovarian cancer.
    Santarosa M, Bidoli E, Gallo A, Steffan A, Boiocchi M, Viel A.
    Oncol Rep; 2002 Jul 06; 9(3):639-44. PubMed ID: 11956643
    [Abstract] [Full Text] [Related]

  • 14. A CAG repeat polymorphism in the androgen receptor gene is associated with reduced bone mass and increased risk of osteoporotic fractures.
    Langdahl BL, Stenkjaer L, Carstens M, Tofteng CL, Eriksen EF.
    Calcif Tissue Int; 2003 Sep 06; 73(3):237-43. PubMed ID: 14667136
    [Abstract] [Full Text] [Related]

  • 15. Androgen receptor gene CAG repeat polymorphism and breast cancer risk in Iranian women: a case-control study.
    Mehdipour P, Pirouzpanah S, Kheirollahi M, Atri M.
    Breast J; 2011 Sep 06; 17(1):39-46. PubMed ID: 21159020
    [Abstract] [Full Text] [Related]

  • 16. Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk.
    Modugno F, Weissfeld JL, Trump DL, Zmuda JM, Shea P, Cauley JA, Ferrell RE.
    Clin Cancer Res; 2001 Oct 06; 7(10):3092-6. PubMed ID: 11595700
    [Abstract] [Full Text] [Related]

  • 17. Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype.
    Dagan E, Friedman E, Paperna T, Carmi N, Gershoni-Baruch R.
    Eur J Hum Genet; 2002 Nov 06; 10(11):724-8. PubMed ID: 12404104
    [Abstract] [Full Text] [Related]

  • 18. Shorter CAG repeat length in the AR gene is associated with poor outcome in head and neck cancer.
    Rosa FE, dos Santos RM, Poli-Frederico RC, Canevari Rde A, Nishimoto IN, Magrin J, Rainho CA, Kowalski LP, Rogatto SR.
    Arch Oral Biol; 2007 Aug 06; 52(8):732-9. PubMed ID: 17321486
    [Abstract] [Full Text] [Related]

  • 19. The androgen receptor gene GGN microsatellite and prostate cancer risk.
    Platz EA, Giovannucci E, Dahl DM, Krithivas K, Hennekens CH, Brown M, Stampfer MJ, Kantoff PW.
    Cancer Epidemiol Biomarkers Prev; 1998 May 06; 7(5):379-84. PubMed ID: 9610786
    [Abstract] [Full Text] [Related]

  • 20. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
    Shu XO, Cai Q, Gao YT, Wen W, Jin F, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 06; 12(12):1462-7. PubMed ID: 14693738
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.